Ole Nome

Central nervous system involvement following diagnosis ofnon-Hodgkin’s lymphoma: a risk model

Åse Hollender, Ole Nome, Eva Skovlund et al. · Annals of Oncology · 2002 · 260 citations

Medicine, Neurology, Oncology +8

High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression

Ketil Heimdal, Henry Hirschberg, Haldor Sletteb� et al. · Journal of Neuro-Oncology · 1992 · 173 citations

Medicine, Pharmacotherapy, Pain Management +10

Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age.

Jenny Foss Abrahamsen, A Andersen, Einar Hannisdal et al. · Journal of Clinical Oncology · 1993 · 159 citations

Medicine, Geriatric Medicine, Oncology +17

Late Medical Complications and Fatigue in Hodgkin’s Disease Survivors

Heidi Knobel, Jon Håvard Loge, May Brit Lund et al. · Journal of Clinical Oncology · 2001 · 121 citations

Medicine, Internal Medicine, Palliative Care +13

Long-term risk of second malignancy after treatment of Hodgkin’s disease: the influence of treatment, age andfollow-up time

A. F. Abrahamsen, A Andersen, Ole Nome et al. · Annals of Oncology · 2002 · 111 citations

Medicine, Oncology, Cancer Epidemiology +12